Using risk analysis to ensure patients' medication safety during hospital relocations and evacuations.

emergency medicine facility design and construction organization and administration quality of health care safety

Journal

European journal of hospital pharmacy : science and practice
ISSN: 2047-9956
Titre abrégé: Eur J Hosp Pharm
Pays: England
ID NLM: 101578294

Informations de publication

Date de publication:
11 2021
Historique:
received: 26 11 2020
revised: 08 03 2021
accepted: 09 03 2021
pubmed: 10 4 2021
medline: 2 4 2022
entrez: 9 4 2021
Statut: ppublish

Résumé

To ensure patient safety and the preparedness of medication processes during hospital relocations and evacuations by using Failure Modes, Effects, and Criticality Analysis (FMECA). The relocation of six regional hospitals to a single building, resulting in 400 beds being moved, could be compared with an emergency evacuation. An FMECA was performed on the hospital group's internal medicine and intensive care units (IMU and ICU), examining how medication processes would be affected by a hospital relocation or evacuation. We identified 59 hospital relocation and 68 evacuation failure modes. Failure modes were ranked based on their criticality index (CI; range 1-810). The higher the CI, the greater the patient-related risk. Average initial IMU and ICU hospital relocation CI scores were 160 (range 105-294) and 201 (range 125-343), respectively, subsequently reduced to 32 (-80%) and 49 (-76%) after mitigation measures. Average initial IMU and ICU evacuation CI scores were 319 (range 245-504) and 592 (range 441-810), respectively, subsequently reduced to 194 (-39%) and 282 (-52%). Most mitigation measures (17/22), such as for example checklists, could be implemented in both situations. Due to their unpredictable nature, five measures were specific to evacuation situations. This study highlights the value of using an FMECA on medication processes to anticipate potential negative impacts on patient safety during hospital relocations or evacuations. Preparation for a hospital relocation can provide useful knowledge and an opportunity to test mitigation measures that might prove useful in evacuations.

Identifiants

pubmed: 33832916
pii: ejhpharm-2020-002619
doi: 10.1136/ejhpharm-2020-002619
pmc: PMC8640418
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e171-e179

Informations de copyright

© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: PB received a grant-in-aid from the Swiss Federal Department of Defense, Civil Protection, and Sport, through the Centre of Competence for Military and Disaster Medicine.

Références

Int J Occup Saf Ergon. 2017 Dec;23(4):589-591
pubmed: 27935431
Am J Health Syst Pharm. 2018 Oct 1;75(19):1493-1517
pubmed: 30257844
J Nurs Adm. 2014 Oct;44(10):535-40
pubmed: 25280076
Disaster Med Public Health Prep. 2017 Aug;11(4):479-486
pubmed: 28115033
Hosp Pharm. 1994 Apr;29(4):331-2, 334-6, 339
pubmed: 10133462
Int J Clin Pharm. 2014 Oct;36(5):953-62
pubmed: 24997014
Aust Health Rev. 2002;25(2):155-61
pubmed: 12046143
Aust Crit Care. 2016 May;29(2):55-60
pubmed: 26602862
Health Facil Manage. 2005 Nov;18(11):29-34
pubmed: 16396279
Ir J Med Sci. 2017 Nov;186(4):815-820
pubmed: 27822907
Crit Care Nurs Q. 2017 Jan/Mar;40(1):59-66
pubmed: 27893510
PLoS One. 2013 Jun 20;8(6):e68856
pubmed: 23818992
Emerg Med Australas. 2013 Dec;25(6):496-502
pubmed: 24224553
Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e164-e170
pubmed: 33727217
Int J Health Care Qual Assur. 2017 Mar 13;30(2):175-186
pubmed: 28256927
J Eval Clin Pract. 2015 Aug;21(4):549-59
pubmed: 25847021
Eur J Intern Med. 2017 Mar;38:30-37
pubmed: 27890453
Hosp Pediatr. 2018 Mar;8(3):148-156
pubmed: 29449317
J Intensive Care Soc. 2016 Nov;17(4):326-331
pubmed: 28979517
Am J Emerg Med. 2018 Oct;36(10):1727-1732
pubmed: 29475633
Ann Pharmacother. 2013 Feb;47(2):237-56
pubmed: 23386063
Am J Disaster Med. 2015;10(4):301-7
pubmed: 27149311
Clin Perform Qual Health Care. 1996 Jul-Sep;4(3):148-53
pubmed: 10159303
Arch Surg. 2009 Sep;144(9):859-64
pubmed: 19797112
BMC Emerg Med. 2008 May 01;8:7
pubmed: 18452615
Crit Care Nurse. 2015 Oct;35(5):16-25
pubmed: 26427972
J Healthc Qual. 2018 Jan/Feb;40(1):58-65
pubmed: 29300275
Qual Saf Health Care. 2005 Apr;14(2):93-8
pubmed: 15805453
Prehosp Disaster Med. 2017 Jun;32(3):321-328
pubmed: 28300525

Auteurs

Laurence Schumacher (L)

Pharmacy of Eastern Vaud Hospitals, Rennaz, Switzerland.
Specialised Centre for Emergency and Disaster Pharmacy, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Florian Berthaudin (F)

Specialised Centre for Emergency and Disaster Pharmacy, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Anne-Laure Blanc (AL)

Pharmacy of Eastern Vaud Hospitals, Rennaz, Switzerland.

Cédric Blatrie (C)

Pharmacy of Eastern Vaud Hospitals, Rennaz, Switzerland.

Anthony Staines (A)

Vaud Hospital Federation, Prilly, Switzerland.
Université Jean Moulin Lyon 3 IFROSS, Lyon, Auvergne-Rhône-Alpes, France.

Pascal Bonnabry (P)

Specialised Centre for Emergency and Disaster Pharmacy, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Pharmacy of the Geneva University Hospitals, Geneva, Switzerland.

Nicolas Widmer (N)

Pharmacy of Eastern Vaud Hospitals, Rennaz, Switzerland Nicolas.Widmer@unige.ch.
Specialised Centre for Emergency and Disaster Pharmacy, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH